vs

Side-by-side financial comparison of Bowhead Specialty Holdings Inc. (BOW) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $151.7M, roughly 1.3× Bowhead Specialty Holdings Inc.). Bowhead Specialty Holdings Inc. runs the higher net margin — 9.8% vs 6.7%, a 3.1% gap on every dollar of revenue. Bowhead Specialty Holdings Inc. produced more free cash flow last quarter ($326.0M vs $17.6M).

Bowhead Specialty Holdings Inc. is a specialty insurance holding company that offers a diversified portfolio of property and casualty insurance products, focusing on underserved niche market segments primarily across North America. It provides tailored risk management solutions and specialized coverage options for both commercial and individual clients.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

BOW vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$151.7M
BOW
Higher net margin
BOW
BOW
3.1% more per $
BOW
9.8%
6.7%
RGEN
More free cash flow
BOW
BOW
$308.5M more FCF
BOW
$326.0M
$17.6M
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOW
BOW
RGEN
RGEN
Revenue
$151.7M
$197.9M
Net Profit
$14.8M
$13.3M
Gross Margin
52.5%
Operating Margin
11.7%
9.0%
Net Margin
9.8%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.44
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOW
BOW
RGEN
RGEN
Q4 25
$151.7M
$197.9M
Q3 25
$143.9M
$188.8M
Q2 25
$133.3M
$182.4M
Q1 25
$122.7M
$169.2M
Q4 24
$174.1M
Q3 24
$116.8M
$154.9M
Q2 24
$98.9M
$154.1M
Q1 24
$151.3M
Net Profit
BOW
BOW
RGEN
RGEN
Q4 25
$14.8M
$13.3M
Q3 25
$15.2M
$14.9M
Q2 25
$12.3M
$14.9M
Q1 25
$11.4M
$5.8M
Q4 24
$-30.3M
Q3 24
$12.1M
$-654.0K
Q2 24
$5.5M
$3.3M
Q1 24
$2.1M
Gross Margin
BOW
BOW
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
BOW
BOW
RGEN
RGEN
Q4 25
11.7%
9.0%
Q3 25
13.3%
8.9%
Q2 25
11.9%
7.6%
Q1 25
11.8%
3.9%
Q4 24
-17.7%
Q3 24
13.5%
-5.1%
Q2 24
7.5%
1.0%
Q1 24
1.3%
Net Margin
BOW
BOW
RGEN
RGEN
Q4 25
9.8%
6.7%
Q3 25
10.5%
7.9%
Q2 25
9.3%
8.2%
Q1 25
9.3%
3.4%
Q4 24
-17.4%
Q3 24
10.4%
-0.4%
Q2 24
5.6%
2.2%
Q1 24
1.4%
EPS (diluted)
BOW
BOW
RGEN
RGEN
Q4 25
$0.44
$0.24
Q3 25
$0.45
$0.26
Q2 25
$0.36
$0.26
Q1 25
$0.34
$0.10
Q4 24
$-0.55
Q3 24
$0.36
$-0.01
Q2 24
$0.20
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOW
BOW
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$193.5M
$767.6M
Total DebtLower is stronger
$146.4M
$542.2M
Stockholders' EquityBook value
$448.3M
$2.1B
Total Assets
$2.4B
$2.9B
Debt / EquityLower = less leverage
0.33×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOW
BOW
RGEN
RGEN
Q4 25
$193.5M
$767.6M
Q3 25
$197.9M
$748.7M
Q2 25
$114.8M
$708.9M
Q1 25
$88.0M
$697.2M
Q4 24
$757.4M
Q3 24
$132.9M
$784.0M
Q2 24
$180.3M
$809.1M
Q1 24
$780.6M
Total Debt
BOW
BOW
RGEN
RGEN
Q4 25
$146.4M
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BOW
BOW
RGEN
RGEN
Q4 25
$448.3M
$2.1B
Q3 25
$430.2M
$2.1B
Q2 25
$407.2M
$2.1B
Q1 25
$391.0M
$2.0B
Q4 24
$2.0B
Q3 24
$364.7M
$2.0B
Q2 24
$339.9M
$2.0B
Q1 24
$2.0B
Total Assets
BOW
BOW
RGEN
RGEN
Q4 25
$2.4B
$2.9B
Q3 25
$2.1B
$2.9B
Q2 25
$1.9B
$2.9B
Q1 25
$1.8B
$2.9B
Q4 24
$2.8B
Q3 24
$1.5B
$2.8B
Q2 24
$1.4B
$2.9B
Q1 24
$2.8B
Debt / Equity
BOW
BOW
RGEN
RGEN
Q4 25
0.33×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOW
BOW
RGEN
RGEN
Operating Cash FlowLast quarter
$331.6M
$25.7M
Free Cash FlowOCF − Capex
$326.0M
$17.6M
FCF MarginFCF / Revenue
214.9%
8.9%
Capex IntensityCapex / Revenue
3.7%
4.1%
Cash ConversionOCF / Net Profit
22.34×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$593.4M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOW
BOW
RGEN
RGEN
Q4 25
$331.6M
$25.7M
Q3 25
$114.7M
$48.1M
Q2 25
$109.0M
$28.6M
Q1 25
$47.7M
$15.0M
Q4 24
$39.2M
Q3 24
$119.4M
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
BOW
BOW
RGEN
RGEN
Q4 25
$326.0M
$17.6M
Q3 25
$113.5M
$43.4M
Q2 25
$107.4M
$21.5M
Q1 25
$46.5M
$11.4M
Q4 24
$33.6M
Q3 24
$118.4M
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
BOW
BOW
RGEN
RGEN
Q4 25
214.9%
8.9%
Q3 25
78.8%
23.0%
Q2 25
80.6%
11.8%
Q1 25
37.9%
6.8%
Q4 24
19.3%
Q3 24
101.4%
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
BOW
BOW
RGEN
RGEN
Q4 25
3.7%
4.1%
Q3 25
0.9%
2.5%
Q2 25
1.2%
3.9%
Q1 25
1.0%
2.1%
Q4 24
3.2%
Q3 24
0.9%
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
BOW
BOW
RGEN
RGEN
Q4 25
22.34×
1.93×
Q3 25
7.56×
3.23×
Q2 25
8.83×
1.92×
Q1 25
4.18×
2.57×
Q4 24
Q3 24
9.88×
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons